536 related articles for article (PubMed ID: 18758466)
1. Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway.
Cao W; Manicassamy S; Tang H; Kasturi SP; Pirani A; Murthy N; Pulendran B
Nat Immunol; 2008 Oct; 9(10):1157-64. PubMed ID: 18758466
[TBL] [Abstract][Full Text] [Related]
2. Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons.
Lekmine F; Uddin S; Sassano A; Parmar S; Brachmann SM; Majchrzak B; Sonenberg N; Hay N; Fish EN; Platanias LC
J Biol Chem; 2003 Jul; 278(30):27772-80. PubMed ID: 12759354
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin has suppressive and stimulatory effects on human plasmacytoid dendritic cell functions.
Boor PP; Metselaar HJ; Mancham S; van der Laan LJ; Kwekkeboom J
Clin Exp Immunol; 2013 Dec; 174(3):389-401. PubMed ID: 23968562
[TBL] [Abstract][Full Text] [Related]
4. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation.
Gotoh K; Tanaka Y; Nishikimi A; Nakamura R; Yamada H; Maeda N; Ishikawa T; Hoshino K; Uruno T; Cao Q; Higashi S; Kawaguchi Y; Enjoji M; Takayanagi R; Kaisho T; Yoshikai Y; Fukui Y
J Exp Med; 2010 Apr; 207(4):721-30. PubMed ID: 20231379
[TBL] [Abstract][Full Text] [Related]
5. Myxoma virus induces type I interferon production in murine plasmacytoid dendritic cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-dependent pathway.
Dai P; Cao H; Merghoub T; Avogadri F; Wang W; Parikh T; Fang CM; Pitha PM; Fitzgerald KA; Rahman MM; McFadden G; Hu X; Houghton AN; Shuman S; Deng L
J Virol; 2011 Oct; 85(20):10814-25. PubMed ID: 21835795
[TBL] [Abstract][Full Text] [Related]
6. Blimp-1-Mediated Pathway Promotes Type I IFN Production in Plasmacytoid Dendritic Cells by Targeting to Interleukin-1 Receptor-Associated Kinase M.
Ko YA; Chan YH; Liu CH; Liang JJ; Chuang TH; Hsueh YP; Lin YL; Lin KI
Front Immunol; 2018; 9():1828. PubMed ID: 30131810
[TBL] [Abstract][Full Text] [Related]
7. The antiviral immune response in human conventional dendritic cells is controlled by the mammalian target of rapamycin.
Fekete T; Pazmandi K; Szabo A; Bacsi A; Koncz G; Rajnavölgyi E
J Leukoc Biol; 2014 Oct; 96(4):579-89. PubMed ID: 25001862
[TBL] [Abstract][Full Text] [Related]
8. Phthalates suppress type I interferon in human plasmacytoid dendritic cells via epigenetic regulation.
Kuo CH; Hsieh CC; Kuo HF; Huang MY; Yang SN; Chen LC; Huang SK; Hung CH
Allergy; 2013 Jul; 68(7):870-9. PubMed ID: 23738920
[TBL] [Abstract][Full Text] [Related]
9. Phospholipid scramblase 1 regulates Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells.
Talukder AH; Bao M; Kim TW; Facchinetti V; Hanabuchi S; Bover L; Zal T; Liu YJ
Cell Res; 2012 Jul; 22(7):1129-39. PubMed ID: 22453241
[TBL] [Abstract][Full Text] [Related]
10. Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells.
Wang J; Lau KY; Jung J; Ravindran P; Barrat FJ
Eur J Immunol; 2014 Apr; 44(4):1130-6. PubMed ID: 24375473
[TBL] [Abstract][Full Text] [Related]
11. IRF-7 is the master regulator of type-I interferon-dependent immune responses.
Honda K; Yanai H; Negishi H; Asagiri M; Sato M; Mizutani T; Shimada N; Ohba Y; Takaoka A; Yoshida N; Taniguchi T
Nature; 2005 Apr; 434(7034):772-7. PubMed ID: 15800576
[TBL] [Abstract][Full Text] [Related]
12. Involvement of DNA-PKcs in the type I IFN response to CpG-ODNs in conventional dendritic cells in TLR9-dependent or -independent manners.
Ma C; Spies NP; Gong T; Jones CX; Chu WM
PLoS One; 2015; 10(3):e0121371. PubMed ID: 25812014
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of the p70 S6 kinase pathway by interferon alpha (IFNalpha) and imatinib mesylate (STI571) in chronic myelogenous leukemia cells.
Parmar S; Smith J; Sassano A; Uddin S; Katsoulidis E; Majchrzak B; Kambhampati S; Eklund EA; Tallman MS; Fish EN; Platanias LC
Blood; 2005 Oct; 106(7):2436-43. PubMed ID: 15790787
[TBL] [Abstract][Full Text] [Related]
15. Human Plasmacytoid and Monocyte-Derived Dendritic Cells Display Distinct Metabolic Profile Upon RIG-I Activation.
Fekete T; Sütö MI; Bencze D; Mázló A; Szabo A; Biro T; Bacsi A; Pazmandi K
Front Immunol; 2018; 9():3070. PubMed ID: 30622542
[TBL] [Abstract][Full Text] [Related]
16. Antiviral protein Viperin promotes Toll-like receptor 7- and Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells.
Saitoh T; Satoh T; Yamamoto N; Uematsu S; Takeuchi O; Kawai T; Akira S
Immunity; 2011 Mar; 34(3):352-63. PubMed ID: 21435586
[TBL] [Abstract][Full Text] [Related]
17. The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells.
Janovec V; Aouar B; Font-Haro A; Hofman T; Trejbalova K; Weber J; Chaperot L; Plumas J; Olive D; Dubreuil P; Nunès JA; Stranska R; Hirsch I
Front Immunol; 2018; 9():364. PubMed ID: 29535732
[TBL] [Abstract][Full Text] [Related]
18. Mammalian target of rapamycin (mTOR) regulates TLR3 induced cytokines in human oral keratinocytes.
Zhao J; Benakanakere MR; Hosur KB; Galicia JC; Martin M; Kinane DF
Mol Immunol; 2010; 48(1-3):294-304. PubMed ID: 20728939
[TBL] [Abstract][Full Text] [Related]
19. Regulation of type I interferon responses by mitochondria-derived reactive oxygen species in plasmacytoid dendritic cells.
Agod Z; Fekete T; Budai MM; Varga A; Szabo A; Moon H; Boldogh I; Biro T; Lanyi A; Bacsi A; Pazmandi K
Redox Biol; 2017 Oct; 13():633-645. PubMed ID: 28818792
[TBL] [Abstract][Full Text] [Related]
20. Human Metapneumovirus M2-2 Protein Acts as a Negative Regulator of Alpha Interferon Production by Plasmacytoid Dendritic Cells.
Kitagawa Y; Sakai M; Funayama M; Itoh M; Gotoh B
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
